Atlas Venture Fund X, Shareholder: Kymera Therapeutics KYMR Planned sale · Filed 04/22

Trade details

Type: Planned sale notice
Stock: Kymera Therapeutics KYMR
Person: Atlas Venture Fund XShareholder
Planned sale date: 26/04/22
Filed: 26/04/22

More to sell after $8.2M in 3 months

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 03/23~05/22

Atlas Venture Fund X's recent trades

Atlas Venture Fund XShareholder
Planned saleDisc Medicine
Planned sale
Disc Medicine
IRON
$175.6K
2,212 sh
$175.6K
Filed 09/04
Traded 09/04
Atlas Venture Fund XShareholder
Planned saleDisc Medicine
Planned sale
Disc Medicine
IRON
$546.1K
6,822 sh
$546.1K
Filed 09/03
Traded 09/03
Atlas Venture Fund XShareholder
Planned saleDisc Medicine
Planned sale
Disc Medicine
IRON
$5.1M
64,460 sh
$5.1M
Filed 09/02
Traded 09/02
Atlas Venture Fund XShareholder
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$7.2M
66,177 sh
$7.2M
Filed 06/29
Traded 06/29
Atlas Venture Fund XShareholder
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$47.8M
410,427 sh
$47.8M
Filed 06/26
Traded 06/26